首页 | 本学科首页   官方微博 | 高级检索  
   检索      


miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
Authors:Yanqing Liu  Uzair-ur-Rehman  Yu Guo  Hongwei Liang  Rongjie Cheng  Fei Yang  Yeting Hong  Chihao Zhao  Minghui Liu  Mengchao Yu  Xinyan Zhou  Kai Yin  Jiangning Chen  Junfeng Zhang  Chen-Yu Zhang  Feng Zhi  Xi Chen
Abstract:Programmed cell death 4 (PDCD4) is a RNA-binding protein that acts as a tumor suppressor in many cancer types, including colorectal cancer (CRC). During CRC carcinogenesis, PDCD4 protein levels remarkably decrease, but the underlying molecular mechanism for decreased PDCD4 expression is not fully understood. In this study, we performed bioinformatics analysis to identify miRNAs that potentially target PDCD4. We demonstrated miR-181b as a direct regulator of PDCD4. We further showed that activation of IL6/STAT3 signaling pathway increased miR-181b expression and consequently resulted in downregulation of PDCD4 in CRC cells. In addition, we investigated the biological effects of PDCD4 inhibition by miR-181b both in vitro and in vivo and found that miR-181b could promote cell proliferation and migration and suppress apoptosis in CRC cells and accelerate tumor growth in xenograft mice, potentially through targeting PDCD4. Taken together, this study highlights an oncomiR role for miR-181b in regulating PDCD4 in CRC and suggests that miR-181b may be a novel molecular therapeutic target for CRC.
Keywords:microRNA  colorectal cancer  miR-181b  PDCD4  
点击此处可从《蛋白质与细胞》浏览原始摘要信息
点击此处可从《蛋白质与细胞》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号